Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform

Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate recombinant MVA vectors from chemically synthesized D...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Res Sq
Main Authors: Chiuppesi, Flavia, Salazar, Marcela d’Alincourt, Contreras, Heidi, Nguyen, Vu, Martinez, Joy, Park, Soojin, Nguyen, Jenny, Kha, Mindy, Iniguez, Angelina, Zhou, Qiao, Kaltcheva, Teodora, Levytskyy, Roman, Ebelt, Nancy, Kang, Tae, Wu, Xiwei, Rogers, Tom, Manuel, Edwin, Shostak, Yuriy, Diamond, Don, Wussow, Felix
Formato: Artigo
Idioma:Inglês
Publicado em: American Journal Experts 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373143/
https://ncbi.nlm.nih.gov/pubmed/32702732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-40198/v1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados